Semaglutide
GLP-1 receptor agonist
Acts on the GLP-1 pathway, which is involved in appetite signaling and the sense of fullness after eating. Gastrointestinal effects are common, and the labeling carries important warnings and contraindications.
Care Path
Overview
Men raise weight for very different reasons. These are the ones described most often.
None of these establishes a diagnosis on its own. What they do is give a physician somewhere specific to start.
Evaluation
Before anything is prescribed, Dr. Mimlitz reviews the parts of your history that shape what is reasonable and safe:
Options
Where medication is appropriate, these are the categories most often discussed. They work differently and carry different considerations.
The exact product, formulation and dispensing pharmacy are identified before treatment begins, so you know what you are receiving.
GLP-1 receptor agonist
Acts on the GLP-1 pathway, which is involved in appetite signaling and the sense of fullness after eating. Gastrointestinal effects are common, and the labeling carries important warnings and contraindications.
GIP and GLP-1 receptor agonist
Acts through both the GIP and GLP-1 pathways, which are involved in appetite, fullness and metabolic signaling. Gastrointestinal effects are common, and the labeling carries important warnings and contraindications.
Stimulant-type prescription medication
A stimulant-type medication generally used for short-term weight management. Cardiovascular history, blood pressure and interactions with your other medications are reviewed carefully before it is considered.
Safety
These medicines are useful for some men and wrong for others. The distinction is made in the evaluation, not on a website.
What to expect
Dr. Mimlitz personally conducts every initial evaluation and follow-up visit.
MMI is independent and physician-owned, so the MMI care team coordinating your care knows your plan, communicates clearly and supports consistent follow-through without corporate layers in between. Decisions are individual rather than a standard protocol passed between rotating providers.
Tell us what you are noticing. We schedule a focused visit rather than a rushed one.
Dr. Mimlitz reviews your history, symptoms and lab work with you and explains what they mean.
If treatment is appropriate, you leave understanding the options, the tradeoffs and the next step.
Care is adjusted over time based on how you feel and what your follow-up labs show.
Weight and hormone findings are often reviewed in the same evaluation.
Where growth-hormone signaling and supportive compounds actually stand.
The visit, the review of your labs and the follow-up, described step by step.
Call the office to schedule a focused visit with Dr. Mimlitz.
This page is general education, not medical advice, and it is not a substitute for an evaluation. The information here draws on the primary sources below.